Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates and other specialty chemicals.
It is a high-speed development technology enterprise with inhibitors, pharmaceutical intermediates and impurities as its main products and production, sales and synthesis customization as its main business.
Shanghai Hongqu Biomedical Technology Co., Ltd. is located in beautiful Shanghai, China, established in 2019. It is jointly founded by a number of highly educated and high-level people with senior drug R & D experience. It is a high-speed development technology enterprise with inhibitors, pharmaceutical intermediates and impurities as its main products and production, sales and synthesis customization as its main business.
Production scale: in order to meet the needs of different customers, we can provide the production of products from mg level to tonnage level. The product line of the enterprise is mature and stable.
What challenges do hemophilia gene therapy need to overcome to achieve the dream of curing patients?
What challenges do hemophilia gene therapy need to overcome to achieve the dream of curing patients?
2020-07-16
Rare! 3. 75 days after a pharmaceutical company was listed, Sanofi, Bi and Hillhead were intensively distributed, and bi
Rare! 3. 75 days after a pharmaceutical company was listed, Sanofi, Bi and Hillhead were intensively distributed, and biopharmaceutical launched the \"great asset transfer\"?
2020-07-07
